Randomized, Controlled Trial of Extended-Release Niacin (Niaspan®) to Augment Subacute Ischemic Stroke Recovery
Status:
Completed
Trial end date:
2012-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety, tolerability, and to explore the
possible benefit of extended-release niacin (Niaspan®) in attempting to improve the recovery
of patients after ischemic stroke.